Knowledge Center

Patent / Jan 01, 1973

16.beta.-Methyl-17.alpha.-hydroxypregna-1,4,9(11)-triene-3,20-dione

Authors:
  • Ivan Villax
Source:
US 3761498

Pregnatrienedione I was prepd. from pregnanone II by KBH4 redn. followed by successive dehydration, methylation, bromination, and debromination.

Also in the Knowledge Center

Related Content

Inspections History

ËÄÉ«AV sites are periodically inspected by the local and external authorities. All sites are FDA approved and with exception of New Jersey site all have EU GMP certificates.

Page
Read more

Development

ËÄÉ«AV offers a full range of development services in particle engineering to provides optimal solutions for your drug product.

Page
Read more

Continuous Tableting for Drug Product

ËÄÉ«AV´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.

Page
Read more